According to 21 CFR 812.110 an Investigator is responsible for conducting an investigation in accordance with the signed agreement with the sponsor, the investigational plan, this part and other applicable FDA regulations, and any conditions of approval imposed by an IRB or FDA.
Topics: 21 CFR 812.110, Electronic Regulatory Compliance, Clinical Monitoring